MAPK1 and breast cancer: Although the FGFR1/MEK/ERK pathway has been shown to promote stemness in both Triple-negative breast cancer (TNBC) cell line MDA-MB-231 [62] and luminal A breast cancer cells [63], there are other mechanisms that can be considered.